Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionGeneos Wealth Management Inc.
Latest Disclosed Ownership101 shares
Latest Disclosed Value $ 45,101
Geneos Wealth Management Inc. reports 0.98% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 4, 2026 - Geneos Wealth Management Inc. filed a 13F-HR form disclosing ownership of 101 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $45,101 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 102 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -0.98% during the quarter. The current value of the position is $45,130 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 101 -1 -0.98 45 -2.17 0.0010
2026-01-28 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 102 -15 -12.82 46 2.22 0.0011
2025-10-22 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 117 -1,775 -93.82 46 -94.66 0.0012
2025-08-18 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,892 65 3.56 842 -4.86 0.0206
2025-05-21 2025-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,827 374 25.74 886 51.28 0.0297
2025-05-08 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,086 1,633 1,496 0.0378
2025-01-21 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,453 -244 -14.38 585 -25.86 0.0205
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,697 1,623 2,193.24 789 2,220.59 0.0301
2024-07-23 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 74 5 7.25 35 21.43 0.0015
2024-05-03 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 69 -15 -17.86 29 -17.65 0.0013
2024-01-26 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 84 -107 -56.02 34 -48.48 0.0017
2023-10-11 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 191 54 39.42 66 37.50 0.0034
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 137 130 1,857.14 48 2,300.00 0.0025
2023-04-25 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7 -120 -94.49 2 -94.44 0.0001
2023-01-31 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 127 0 0.00 37 0.00 0.0022
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 127 -318 -71.46 36 -71.65 0.0025
2022-07-22 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 445 0 0.00 127 9.48 0.0063
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 445 120 36.92 116 63.38 0.0050
2022-02-09 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 325 100 44.44 71 77.50 0.0027
2021-11-09 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 225 1 0.45 40 -9.09 0.0015
2021-07-08 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 224 -2,380 -91.40 44 -92.25 0.0017
2021-06-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,604 -354 -11.97 568 -6.12 0.0159
2021-05-19 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,958 2,350 386.51 605 271.17 0.0243
2021-09-07 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 608 -300 -33.04 163 -37.07 0.0084
2021-09-07 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 908 270 42.32 259 87.68 0.0144
2021-09-07 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 638 100 18.59 138 16.95 0.0093
2021-09-07 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 538 0 0.00 118 32.58 0.0063
2021-09-07 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 538 14 2.67 89 -7.29 0.0053
2021-09-07 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 524 -50 -8.71 96 -8.57 0.0060
2021-09-07 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 574 -24 -4.01 105 9.38 0.0069
2021-09-07 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 598 0 0.00 96 -16.52 0.0071
2021-09-07 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 598 29 5.10 115 19.79 0.0077
2021-09-07 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 569 -70 -10.95 96 -7.69 0.0075
2021-09-07 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 639 0 0.00 104 9.47 0.0091
2021-09-07 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 639 -67 -9.49 95 -11.21 0.0085
2021-09-07 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 706 453 179.05 107 234.38 0.0106
2021-09-07 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 253 0 0.00 32 18.52 0.0033
2021-09-07 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 253 -22 -8.00 27 35.00 0.0028
2021-09-07 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 275 0 0.00 20 -13.04 0.0026
2021-09-07 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 275 22 8.70 23 4.55 0.0031
2021-09-07 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 253 0 0.00 22 10.00 0.0032
2021-09-07 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 253 253 20 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.